Pancreatic Cancer Research

Journal articleEur J Clin Invest2016

Sitagliptin and pancreatic cancer risk in patients with type 2 diabetes.

Journal
Eur J Clin Invest
Published
17 December 2015
Citations
31
Type
Article

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract license unknown

Background The risk of pancreatic cancer associated with incretin-based therapies is controversial. Methods This study retrospectively analysed the National Health Insurance database including patients with newly diagnosed type 2 diabetes mellitus at an age ≥ 25 years between 1999 and 2010. … Excerpt only: this text is the publisher’s. Read it in full at the source.